REmote COnditioning in Out-of-Hospital Cardiac Arrest
Condition(s) studied
Investigational drug(s) / intervention(s)
Remote ischemic conditioning: A brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of four cycles of a 5-min brachial cuff inflation at 200 mmHg followed by a 5-min of cuff deflation, and is started as soon as possible after randomization. The intervention is repeated 12 and 24 hours after inclusion.
No remote ischemic conditioning: A brachial cuff is positioned around the arm of the patient and no inflation or deflation is performed.
Study summary
Out-of-Hospital Cardiac Arrest remains a major public health problem, resulting in high mortality largely related to multiple organ failure and poor neurological outcomes due to brain anoxia. The pathophysiology of organ dysfunction after resuscitated out-of-hospital cardiac arrest involves ischemia-reperfusion processes. Remote ischemic conditioning is a therapeutic strategy used to protect organs against the detrimental effects of ischemia-reperfusion injury.
The objective of the present trial is to determine whether remote ischemic conditioning performed early after out-of-hospital cardiac arrest can decrease mortality, or multiple organ failure and/or severe neurological failure.
Eligibility
Primary outcome measure(s)
- All cause of death — 72 hours after hospital admission
All-cause death will be assessed 72 hours after hospital admission. - Multiple organ failure — 72 hours after hospital admission
Multiple organ failure is defined by a SOFA (Sepsis-related Organ Failure Assessment) score, censored for the neurological component, greater than or equal to 5. - Severe neurological failure — 72 hours after hospital admission
Severe neurological failure is defined by a motor component of the Glasgow Coma Score less than or equal to 3, without confounding factors (hypothermia less than or equal to 35.0°C, and/or sedation/analgesia/curarization). The glasgow coma score ranges from 3 to 15 and is broken down into its three parameters: eye opening, verbal response and motor response. The higher the score, the better the patient's recovery.
Trial sites (14)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital Louis Pradel | Bron | France | Not Yet Recruiting |
| Hôpital Gabriel Montpied, CHU de Clermont Ferrand | Clermont-Ferrand | France | Not Yet Recruiting |
| Centre Jean Perrin, Clermont-Ferrand | Clermont-Ferrand | France | Not Yet Recruiting |
| Hôpital F Mitterrand, CHU de Dijon | Dijon | France | Not Yet Recruiting |
| Hôpital Albert Michallon, CHU de Grenoble | La Tronche | France | Not Yet Recruiting |
| Hôpital Edouard Herriot | Lyon | France | Recruiting |
| Hôpital Saint-Joseph Saint-Luc | Lyon | France | Recruiting |
| Hôpital de la Timone, CHU de Marseille | Marseille | France | Recruiting |
| Hôpital lapeyronie, CHU de Montpellier | Montpellier | France | Recruiting |
| Hôpital Universitaire Carémeau | Nîmes | France | Not Yet Recruiting |
| Hôpital Lariboisière, APHP, Réanimation Médicale et Toxicologique | Paris | France | Not Yet Recruiting |
| Hôpital Lyon-Sud | Pierre-Bénite | France | Recruiting |
| Hôpital Nord, CHU de St Etienne | Saint-Priest-en-Jarez | France | Recruiting |
| Hôpital Nord-Ouest | Villefranche-sur-Saône | France | Recruiting |
More Hospices Civils de Lyon trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06306625 on ClinicalTrials.gov ↗ ← All trials in France